Critical Comparison: Disaboom (OTCMKTS:MEDH) and Globus Medical (NYSE:GMED)

Disaboom (OTCMKTS:MEDH) and Globus Medical (NYSE:GMED) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations and institutional ownership.

Institutional & Insider Ownership

95.2% of Globus Medical shares are held by institutional investors. 18.5% of Globus Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Disaboom and Globus Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Disaboom	0	0	0	0	0.00
Globus Medical	0	6	8	0	2.57

Globus Medical has a consensus target price of $87.27, suggesting a potential upside of 49.55%. Given Globus Medical’s stronger consensus rating and higher probable upside, analysts clearly believe Globus Medical is more favorable than Disaboom.

Profitability

This table compares Disaboom and Globus Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Disaboom	-3.05%	N/A	N/A
Globus Medical	13.58%	10.65%	8.86%

Risk & Volatility

Disaboom has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, Globus Medical has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500.

Valuation & Earnings

This table compares Disaboom and Globus Medical”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Disaboom	$890,000.00	0.62	-$170,000.00	N/A	N/A
Globus Medical	$2.63 billion	3.00	$102.98 million	$2.60	22.44

Globus Medical has higher revenue and earnings than Disaboom.

Summary

Globus Medical beats Disaboom on 12 of the 12 factors compared between the two stocks.

About Disaboom

Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.

About Globus Medical

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.